Results 21 to 30 of about 951,374 (223)

Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021

Emerging Infectious Diseases, 2022
Ghana is a yellow fever–endemic country and experienced a vaccine-derived polio outbreak in July 2019. A reactive polio vaccination campaign was conducted in September 2019 and preventive yellow fever campaign in November 2020.
Kwame Amponsa-Achiano, Joseph Asamoah Frimpong, Danielle Barradas, Delia Akosua Bandoh, Ernest Kenu   +4 more
doaj   +1 more source

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity [PDF]

, 2012
© 2012 Elsevier Ltd. All rights reservedBackground: The development of a new, more effective vaccine against tuberculosis (TB) for use in healthy and HIV-infected adults, children and infants, remains a global health priority.
Minassian, Angela M, Porter, David W, Pathan, Ansar A, Rowland, Rosalind, Sander, C, Satti, Iman, Angela M Minassian, Nicola Williams, Lawrie, AM, Sander, Clare, Alison M Lawrie, Rowland, R, Poulton, ID, Rosalind Rowland, Brittain, N, Williams, Nicola, Pathan, AA, David W Porter, Minassian, AM, Helen McShane, Iman Satti, Ansar A Pathan, Ian D Poulton, Lawrie, Alison M, Nathaniel Brittain, Williams, N, Brittain, Nathaniel, Poulton, Ian D, Clare Sander, Porter, DW, Satti, I, McShane, H, McShane, Helen   +32 more
core   +1 more source

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. [PDF]

PLoS ONE, 2008
Implementation of yellow fever vaccination is currently hampered by limited supply of vaccine. An alternative route of administration with reduced amounts of vaccine but without loss of vaccine efficacy would boost vaccination programmes.A randomized ...
Anna H Roukens, Ann C Vossen, Peter J Bredenbeek, Jaap T van Dissel, Leo G Visser   +4 more
doaj   +1 more source

Yellow fever outbreak, Imatong, southern Sudan. [PDF]

, 2004
In May 2003, the World Health Organization received reports about a possible outbreak of a hemorrhagic disease of unknown cause in the Imatong Mountains of southern Sudan.
Sang, Rosemary C, Victor O. Ofula, Onyango, Clayton O, Ofula, Victor O, Rodney L. Coldren, Robert Swanepoel, Coldren, Rodney L, Burt, Felicity J, Kevin M. De Cock, Rosemary C. Sang, Okoth, Fredrick A, Tukei, Peter M, Samson L. Konongoi, Abdourahmane Sow, Peter M. Tukei, De Cock, Kenin M, Waters, Norman C, Felicity J. Burt, Sow, Abourahmane, Norman C. Waters, Clayton O. Onyango, Fredrick A. Okoth, Konongoi, Sanson L, Clayton O. Onyango, Swanepoel, Robert   +24 more
core   +1 more source

Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus

Emerging Microbes and Infections, 2021
Yellow fever virus (YFV) is a re-emerging flavivirus, which can lead to severe clinical manifestations and high mortality, with no specific antiviral therapies available.
Hao-Long Dong, Hong-Jiang Wang, Zhong-Yu Liu, Qing Ye, Xiao-Ling Qin, Dan Li, Yong-Qiang Deng, Tao Jiang, Xiao-Feng Li, Cheng-Feng Qin   +9 more
doaj   +1 more source

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Introduction: In December 2016, an outbreak of sylvatic yellow fever (YF) occurred in the non-endemic areas of the south-eastern region of Brazil. The immune response to the yellow fever vaccine and its safety in individuals with chronic kidney disease ...
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +3 more sources

Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

Vaccines, 2019
Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine.
Kay M. Tomashek, Mark Challberg, Seema U. Nayak, Helen F. Schiltz   +3 more
doaj   +1 more source

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine [PDF]

, 2013
BACKGROUND: In two clinical trials, low-grade fever was observed more frequently after coadministration than after separate administration of two recommended routine pediatric vaccines.
Rose, Markus A., William C Gruber, Sherryl Baker, Christine Juergens, Beate Schmoele-Thoma, Gruber, William C., Stefan Zielen, Zielen, Stefan, Jürgens, Christine, Schmoele-Thoma, Beate, Baker, Sherryl, Markus A Rose   +11 more
core   +2 more sources

Investigation of a Q fever outbreak in a Scottish co-located slaughterhouse and cutting plant [PDF]

, 2010
Outbreaks of Q fever are rare in the UK. In 2006, the largest outbreak of Q fever in Scotland occurred at a co-located slaughterhouse and cutting plant with 110 cases.
Pollock, K.G.J., Wilson, L.E., Donaghy, M., Browning, L.M., Stewart, W.C., Young, D., Prempeh, H., Couper, S.   +7 more
core   +4 more sources

Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.

PLoS Neglected Tropical Diseases, 2014
Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano, Zouraide Guerra Antunes Costa, Daniel Garkauskas Ramos, Maria Auxiliadora Andrade, Valéria de Sá Jayme, Marco Antônio Barreto de Almeida, Kátia Campomar Vettorello, Melissa Mascheretti, Brendan Flannery   +8 more
doaj   +1 more source